Background: We aimed to provide a representation of the global burden of stroke. Methods: All cases of stroke were prospectively identified through the population-based registry of Dijon, France (1987–2012). Attack rates and mortality rates (defined as stroke leading to death within 30 days) were standardized to the European standard. Sex differences and temporal trends were evaluated by calculating rate ratios (RRs). Results: In all, 5,285 stroke cases (52.7% women) were recorded. The standardized attack rate was 98.2/100,000/year and the mortality rate was 12/100,000/year, and both were lower in women than in men (RR 0.67, p < 0.001, and RR 0.70, p < 0.001, respectively). Attack rates increased over time (RR 1.016; 95% CI 1.013–1.020) irrespective of the stroke subtype. In contrast, mortality rates declined (RR 0.985; 95% CI 0.976–0.995) with decreasing rates for ischemic stroke but no change for intracerebral hemorrhage and subarachnoid hemorrhage. The sex gap in both attack and mortality rates remained stable. Between the first (1987–1991) and the last (2007–2012) study periods, the annual number of stroke patients who survived beyond 30 days rose by 55%, Conclusions: Increasing attack rates and decreasing mortality have led to a rise in the number of stroke survivors in the population, thus indicating a growing need for the implementation of dedicated services.

Feigin VL, Lawes CM, Bennett DA, Barker-Collo SL, Parag V: Worldwide stroke incidence and early case fatality reported in 56 population-based studies: a systematic review. Lancet Neurol 2009; 8: 355–69.
Béjot Y, Daubail B, Jacquin A, Durier J, Osseby GV, Rouaud O, et al: Trends in the incidence of ischaemic stroke in young adults between 1985 and 2011: the Dijon Stroke Registry. J Neurol Neurosurg Psychiatry 2014; 85: 509–513.
Béjot Y, Grelat M, Delpont B, Durier J, Rouaud O, Osseby GV, et al : Temporal trends in early case-fatality rates in patients with intracerebral hemorrhage. Neurology 2017; 88: 985–990.
Medin J, Nordlund A, Ekberg K; Swedish Hospital Discharge Register: Increasing stroke incidence in Sweden between 1989 and 2000 among persons aged 30 to 65 years: evidence from the swedish hospital discharge register. Stroke 2004; 35: 1047–1051.
George MG, Tong X, Kuklina EV, Labarthe DR: Trends in stroke hospitalizations and associated risk factors among children and young adults, 1995–2008. Ann Neurol 2011; 70: 713–721.
Ramirez L, Kim-Tenser MA, Sanossian N, Cen S, Wen G, He S, et al: Trends in acute ischemic stroke hospitalizations in the United States. J Am Heart Assoc 2016; 5:pii:e003233.
Tibæk M, Dehlendorff C, Jørgensen HS, Forchhammer HB, Johnsen SP, Kammersgaard LP: Increasing incidence of hospitalization for stroke and transient ischemic attack in young adults: a registry-based study. J Am Heart Assoc 2016; 5:pii:e003158.
Kissela BM, Khoury JC, Alwell K, Moomaw CJ, Woo D, Adeoye O, et al: Age at stroke temporal trends in stroke incidence in a large, biracial population. Neurology 2012; 79: 1781–1787.
Sudlow CL, Warlow CP: Comparing stroke incidence worldwide: what makes studies comparable? Stroke 1996; 27: 550–558.
Bennett DA, Brayne C, Feigin VL, Barker-Collo S, Brainin M, Davis D, et al: Development of the Standards of Reporting of Neurological Disorders (STROND) checklist: a guideline for the reporting of incidence and prevalence studies in neuroepidemiology. Neurology 2015; 85: 821–818.
Giroud M, Delpont B, Daubail B, Blanc C, Durier J, Giroud M, et al: Temporal trends in sex differences with regard to stroke incidence: the Dijon stroke registry (1987–2012). Stroke 2017; 48: 846–849.
World Health Organization: The World Health Report 2000: Health Systems Improving Performance. Geneva, World Health Organization, 2000.
Grimaud O, Leray E, Lalloué B, Aghzaf R, Durier J, Giroud M, et al: Mortality following stroke during and after acute care according to neighbourhood deprivation: a disease registry study. J Neurol Neurosurg Psychiatry 2014; 85: 1313–1318.
Feigin VL, Forouzanfar MH, Krishnamurthi R, Mensah GA, Connor M, Bennett DA, et al: Global and regional burden of stroke during 1990–2010: findings from the global burden of disease study 2010. Lancet 2014; 383: 245–254.
Vaartjes I, O’Flaherty M, Capewell S, Kappelle J, Bots M: Remarkable decline in ischemic stroke mortality is not matched by changes in incidence. Stroke 2013: 44: 591–597.
Gillum RF, Kwagyan J, Obisesan TO: Ethnic and geographic variation in stroke mortality trends. Stroke 2011; 42: 3294–3296.
Kunst AE, Amiri M, Janssen F: The decline in stroke mortality: exploration of future trends in 7 western European countries. Stroke 2011; 42: 2126–2130.
Redon J, Olsen MH, Cooper RS, Zurriaga O, Martinez-Beneito MA, Laurent S, et al: Stroke mortality and trends from 1990 to 2006 in 39 countries from Europe and Central Asia: implications for control of high blood pressure. Eur Heart J 2011; 32: 1424–1431.
Béjot Y, Aouba A, de Peretti C, Grimaud O, Aboa-Eboulé C, Chin F, et al: Time trends in hospital-referred stroke and transient ischemic attack: results of a 7-year nationwide survey in France. Cerebrovasc Dis 2010; 30: 346–354.
Béjot Y, Aboa-Eboulé C, Jacquin A, Troisgros O, Hervieu M, Durier J, et al: Stroke care organization overcomes the deleterious ‘weekend effect’ on 1-month stroke mortality: a population-based study. Eur J Neurol 2013; 20: 1177–1183.
Teuschl Y, Brainin M, Matz K, Dachenhausen A, Ferrari J, Seyfang L, et al: Time trends in patient characteristics treated on acute stroke-units: results from the Austrian stroke unit registry 2003–2011. Stroke 2013; 44: 1070–104.
Truelsen T, Piechowski-Jóźwiak B, Bonita R, Mathers C, Bogousslavsky J, Boysen G: Stroke incidence and prevalence in Europe: a review of available data. Eur J Neurol 2006; 13: 581–598.
Appelros P, Stegmayr B, Terént A: Sex differences in stroke epidemiology: a systematic review. Stroke 2009; 40: 1082–1090.
Roach RE, Helmerhorst FM, Lijfering WM, Stijnen T, Algra A, Dekkers OM: Combined oral contraceptives: the risk of myocardial infarction and ischemic stroke. Cochrane Database Syst Rev 2015; 8:CD011054.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.